ciprofloxacin has been researched along with Carcinoma, Non-Small Cell Lung in 11 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin is an antibiotic that belongs to fluoroquinoles, characterized by broad spectrum of action against pathogens, especially Gram(-) aerobic bacilli." | 2.46 | Does ciprofloxacin have an obverse and a reverse? ( Drewa, T; Gurtowska, N; Kloskowski, T, 2010) |
| "The primary in vitro one dose anticancer assay experienced promising cytotoxic activity against different cancer cell lines especially non-small cell lung cancer." | 1.43 | New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase. ( Abbas, SH; Abd El-Hafeez, AA; Abdelhafez, EMN; Abuo-Rahma, GEA; Mohammed, HHH, 2016) |
| "Ciprofloxacin was cytostatic only against the A549 cell line." | 1.38 | Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC. ( Adamowicz, J; Dębski, R; Drewa, T; Grzanka, A; Gurtowska, N; Kloskowski, T; Nowak, JM; Olkowska, J; Tworkiewicz, J, 2012) |
| "Ciprofloxacin was given i." | 1.34 | Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients. ( Endo, N; Haraguchi, S; Hioki, M; Kawamura, J; Koizumi, K; Orii, K; Shimizu, K; Takushima, M; Yamashita, K; Yamashita, Y, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Trawneh, SA | 2 |
| Zahra, JA | 2 |
| Kamal, MR | 1 |
| El-Abadelah, MM | 2 |
| Zani, F | 2 |
| Incerti, M | 2 |
| Cavazzoni, A | 2 |
| Alfieri, RR | 1 |
| Petronini, PG | 1 |
| Vicini, P | 2 |
| Al-Taweel, SA | 1 |
| Mohammed, HHH | 1 |
| Abd El-Hafeez, AA | 1 |
| Abbas, SH | 1 |
| Abdelhafez, EMN | 1 |
| Abuo-Rahma, GEA | 1 |
| Papakanderaki, E | 1 |
| Kanakakis, K | 1 |
| Goule, S | 1 |
| Chounti, M | 1 |
| Hountis, P | 1 |
| Phiboonchaiyanan, PP | 1 |
| Kiratipaiboon, C | 1 |
| Chanvorachote, P | 1 |
| Loriot, Y | 1 |
| Ferte, C | 1 |
| Gomez-Roca, C | 1 |
| Moldovan, C | 1 |
| Bahleda, R | 1 |
| Wislez, M | 1 |
| Cadranel, J | 1 |
| Soria, JC | 1 |
| Kloskowski, T | 2 |
| Gurtowska, N | 2 |
| Drewa, T | 2 |
| Schook, RM | 1 |
| Romane, SM | 1 |
| Smit, EF | 1 |
| Egbert, SF | 1 |
| Postmus, PE | 1 |
| Pieter, PE | 1 |
| Hartemink, KJ | 1 |
| Koen, HJ | 1 |
| Paul, MA | 1 |
| Marinus, PA | 1 |
| Olkowska, J | 1 |
| Nowak, JM | 1 |
| Adamowicz, J | 1 |
| Tworkiewicz, J | 1 |
| Dębski, R | 1 |
| Grzanka, A | 1 |
| Haraguchi, S | 1 |
| Hioki, M | 1 |
| Yamashita, K | 1 |
| Orii, K | 1 |
| Yamashita, Y | 1 |
| Kawamura, J | 1 |
| Takushima, M | 1 |
| Endo, N | 1 |
| Koizumi, K | 1 |
| Shimizu, K | 1 |
| Bennett, CL | 1 |
| Smith, TJ | 1 |
| George, SL | 1 |
| Hillner, BE | 1 |
| Fleishman, S | 1 |
| Niell, HB | 1 |
2 reviews available for ciprofloxacin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Does ciprofloxacin have an obverse and a reverse?
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cipr | 2010 |
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
Topics: Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Clinical Trials, Phase III as Topic; Cost-Benefit Ana | 1995 |
9 other studies available for ciprofloxacin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell | 2010 |
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell | 2011 |
New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cel | 2016 |
Clinical significance of positive Raoultella Ornithinolytica and Staphylococcus hominis cultures in a post lobectomy patient. A case report.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Ciprofloxacin; Enterobacteriaceae; Ente | 2018 |
Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Topics: Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Caveolin 1; Cell Line, Tumor; Cell Movement; | 2016 |
Pemetrexed-induced pneumonitis: a case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Non-Small-Ce | 2009 |
Benefit of a second opinion for lung cancer: no recurrent disease, but infection.
Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lun | 2012 |
Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC.
Topics: Actins; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor | 2012 |
Ciprofloxacin penetration into the pulmonary parenchyma in Japanese patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Carcinoma, Non-Small-Cell Lung; Chromatography, High | 2007 |